Dear All (and again with thanks to Arjun Srinivasan for co-authoring this pair of newsletters): In parallel with the newsletter discussing a recent paper on the impact of rapid antimicrobial susceptibility testing (27 May 2026 newsletter, “Limits on measuring the impact of rapid AST”), we have release of an exceptionally well-done classic economic approach showing

Dear All (and with thanks to Arjun Srinivasan for co-authoring this wonkish newsletter — prepare yourself! Know also that we’ve written a parallel newsletter entitled “Economic modeling of the value of rapid diagnostics” that discusses the use of modeling to estimate the value of diagnostics in general): Driven by ongoing work to encourage use as part